Plain-English translation of NCT07341191 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Mantle Cell Lymphoma research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This study is testing a combination of two medications— and —given before you receive , a type of immunotherapy designed to fight your lymphoma. The hope is that these medications will work together to help prepare your cancer for CAR-T treatment and may lead to longer-lasting results without the need for chemotherapy.
Current treatments for advanced mantle cell lymphoma don't always work well or last long enough. Researchers believe that combining these two medications before CAR-T therapy might improve outcomes by using different biological mechanisms that complement each other.
You likely qualify if…
You likely don't qualify if…
You will start by taking (if you're not already on it), then gradually add while continuing during an induction phase. After this combination treatment, you will receive according to your local guidelines, followed by ongoing as maintenance therapy. Even after treatment ends, your doctor will monitor your health for life to track how you're doing and gather important study results.
AI-generated summary from trial data · Jun 12, 2026 · Not medical advice
Canada